| Symbol |
Name |
|
A2M
|
alpha-2-macroglobulin
|
|
A4GALT
|
alpha 1,4-galactosyltransferase
|
|
AAK1
|
AP2 associated kinase 1
|
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCA3
|
ATP-binding cassette, sub-family A (ABC1), member 3
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCC10
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 10
|
|
ABCE1
|
ATP-binding cassette, sub-family E (OABP), member 1
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACACB
|
acetyl-CoA carboxylase beta
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
|
ACVR1
|
activin A receptor, type I
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
|
ADAM15
|
ADAM metallopeptidase domain 15
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADAM33
|
ADAM metallopeptidase domain 33
|
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADAMTS15
|
ADAM metallopeptidase with thrombospondin type 1 motif, 15
|
|
ADAMTS2
|
ADAM metallopeptidase with thrombospondin type 1 motif, 2
|
|
ADAMTS5
|
ADAM metallopeptidase with thrombospondin type 1 motif, 5
|
|
ADAMTS9
|
ADAM metallopeptidase with thrombospondin type 1 motif, 9
|
|
ADGRB1
|
adhesion G protein-coupled receptor B1
|
|
ADGRB3
|
adhesion G protein-coupled receptor B3
|
|
ADGRG1
|
adhesion G protein-coupled receptor G1
|
|
ADH5
|
alcohol dehydrogenase 5 (class III), chi polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
AFP
|
alpha-fetoprotein
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGXT
|
alanine-glyoxylate aminotransferase
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
|
AIFM1
|
apoptosis-inducing factor, mitochondrion-associated, 1
|
|
AIP
|
aryl hydrocarbon receptor interacting protein
|
|
AKAP7
|
A kinase (PRKA) anchor protein 7
|
|
AKR1B1
|
aldo-keto reductase family 1, member B1 (aldose reductase)
|
|
AKR1B10
|
aldo-keto reductase family 1, member B10 (aldose reductase)
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT1S1
|
AKT1 substrate 1 (proline-rich)
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
ALAD
|
aminolevulinate dehydratase
|
|
ALCAM
|
activated leukocyte cell adhesion molecule
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
|
ALOX15B
|
arachidonate 15-lipoxygenase, type B
|
|
ALOX5AP
|
arachidonate 5-lipoxygenase-activating protein
|
|
AMBP
|
alpha-1-microglobulin/bikunin precursor
|
|
AMFR
|
autocrine motility factor receptor, E3 ubiquitin protein ligase
|
|
AMY1A
|
amylase, alpha 1A (salivary)
|
|
ANAPC1
|
anaphase promoting complex subunit 1
|
|
ANG
|
angiogenin, ribonuclease, RNase A family, 5
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANGPTL3
|
angiopoietin-like 3
|
|
ANP32A
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member A
|
|
ANXA5
|
annexin A5
|
|
APC
|
adenomatous polyposis coli
|
|
APCDD1
|
adenomatosis polyposis coli down-regulated 1
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APIP
|
APAF1 interacting protein
|
|
APOB
|
apolipoprotein B
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOC1
|
apolipoprotein C-I
|
|
APOE
|
apolipoprotein E
|
|
APOF
|
apolipoprotein F
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AR
|
androgen receptor
|
|
ARF1
|
ADP-ribosylation factor 1
|
|
ARF6
|
ADP-ribosylation factor 6
|
|
ARG2
|
arginase 2
|
|
ARHGAP35
|
Rho GTPase activating protein 35
|
|
ARHGDIA
|
Rho GDP dissociation inhibitor (GDI) alpha
|
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta
|
|
ARHGEF3
|
Rho guanine nucleotide exchange factor (GEF) 3
|
|
ASAH1
|
N-acylsphingosine amidohydrolase (acid ceramidase) 1
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP2A2
|
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
|
|
ATPIF1
|
ATPase inhibitory factor 1
|
|
ATXN3
|
ataxin 3
|
|
AURKA
|
aurora kinase A
|
|
AURKB
|
aurora kinase B
|
|
AURKC
|
aurora kinase C
|
|
AVEN
|
apoptosis, caspase activation inhibitor
|
|
AXIN1
|
axin 1
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
BACE2
|
beta-site APP-cleaving enzyme 2
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BAG2
|
BCL2-associated athanogene 2
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAMBI
|
BMP and activin membrane-bound inhibitor
|
|
BANF1
|
barrier to autointegration factor 1
|
|
BARD1
|
BRCA1 associated RING domain 1
|
|
BATF
|
basic leucine zipper transcription factor, ATF-like
|
|
BAX
|
BCL2-associated X protein
|
|
BCHE
|
butyrylcholinesterase
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL2L2
|
BCL2-like 2
|
|
BCL3
|
B-cell CLL/lymphoma 3
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCR
|
breakpoint cluster region
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BIRC2
|
baculoviral IAP repeat containing 2
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BIRC7
|
baculoviral IAP repeat containing 7
|
|
BIRC8
|
baculoviral IAP repeat containing 8
|
|
BMP15
|
bone morphogenetic protein 15
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BMPER
|
BMP binding endothelial regulator
|
|
BMPR1A
|
bone morphogenetic protein receptor, type IA
|
|
BMX
|
BMX non-receptor tyrosine kinase
|
|
BPGM
|
2,3-bisphosphoglycerate mutase
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BSG
|
basigin (Ok blood group)
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
BTG2
|
BTG family, member 2
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
BTRC
|
beta-transducin repeat containing E3 ubiquitin protein ligase
|
|
BUB1
|
BUB1 mitotic checkpoint serine/threonine kinase
|
|
BUB1B
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
|
C19ORF33
|
chromosome 19 open reading frame 33
|
|
C1QBP
|
complement component 1, q subcomponent binding protein
|
|
C1S
|
complement component 1, s subcomponent
|
|
C3
|
complement component 3
|
|
C4A
|
complement component 4A (Rodgers blood group)
|
|
C4BPA
|
complement component 4 binding protein, alpha
|
|
C4BPB
|
complement component 4 binding protein, beta
|
|
C5
|
complement component 5
|
|
C5AR1
|
complement component 5a receptor 1
|
|
CA2
|
carbonic anhydrase II
|
|
CA4
|
carbonic anhydrase IV
|
|
CACYBP
|
calcyclin binding protein
|
|
CALM1
|
calmodulin 1 (phosphorylase kinase, delta)
|
|
CAMK2N2
|
calcium/calmodulin-dependent protein kinase II inhibitor 2
|
|
CAMKK2
|
calcium/calmodulin-dependent protein kinase kinase 2, beta
|
|
CAPN1
|
calpain 1, (mu/I) large subunit
|
|
CAPN10
|
calpain 10
|
|
CAPN2
|
calpain 2, (m/II) large subunit
|
|
CARD9
|
caspase recruitment domain family, member 9
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CASP10
|
caspase 10, apoptosis-related cysteine peptidase
|
|
CASP2
|
caspase 2, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CAST
|
calpastatin
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBS
|
cystathionine-beta-synthase
|
|
CCAR2
|
cell cycle and apoptosis regulator 2
|
|
CCDC50
|
coiled-coil domain containing 50
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CCND3
|
cyclin D3
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD177
|
CD177 molecule
|
|
CD226
|
CD226 molecule
|
|
CD274
|
CD274 molecule
|
|
CD28
|
CD28 molecule
|
|
CD34
|
CD34 molecule
|
|
CD38
|
CD38 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD47
|
CD47 molecule
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD58
|
CD58 molecule
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
|
CD63
|
CD63 molecule
|
|
CD82
|
CD82 molecule
|
|
CDC20
|
cell division cycle 20
|
|
CDC25A
|
cell division cycle 25A
|
|
CDC25C
|
cell division cycle 25C
|
|
CDC37
|
cell division cycle 37
|
|
CDC42
|
cell division cycle 42
|
|
CDC6
|
cell division cycle 6
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK11B
|
cyclin-dependent kinase 11B
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK5R1
|
cyclin-dependent kinase 5, regulatory subunit 1 (p35)
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDK7
|
cyclin-dependent kinase 7
|
|
CDK9
|
cyclin-dependent kinase 9
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDKN2C
|
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)
|
|
CDKN2D
|
cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4)
|
|
CDKN3
|
cyclin-dependent kinase inhibitor 3
|
|
CDX2
|
caudal type homeobox 2
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHFR
|
checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase
|
|
CHGA
|
chromogranin A
|
|
CHKA
|
choline kinase alpha
|
|
CHKB
|
choline kinase beta
|
|
CHRD
|
chordin
|
|
CHRM3
|
cholinergic receptor, muscarinic 3
|
|
CIB1
|
calcium and integrin binding 1 (calmyrin)
|
|
CIRBP
|
cold inducible RNA binding protein
|
|
CKAP4
|
cytoskeleton-associated protein 4
|
|
CLCA2
|
chloride channel accessory 2
|
|
CLCN2
|
chloride channel, voltage-sensitive 2
|
|
CLDN11
|
claudin 11
|
|
CLDN4
|
claudin 4
|
|
CLEC4G
|
C-type lectin domain family 4, member G
|
|
CLMP
|
CXADR-like membrane protein
|
|
CLTC
|
clathrin, heavy chain (Hc)
|
|
CMA1
|
chymase 1, mast cell
|
|
CNN2
|
calponin 2
|
|
CNOT12
|
CCR4-NOT transcription complex subunit 12
|
|
COL4A6
|
collagen, type IV, alpha 6
|
|
COX10
|
COX10 heme A:farnesyltransferase cytochrome c oxidase assembly factor
|
|
CPA4
|
carboxypeptidase A4
|
|
CPB1
|
carboxypeptidase B1 (tissue)
|
|
CPB2
|
carboxypeptidase B2 (plasma)
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREBBP
|
CREB binding protein
|
|
CRH
|
corticotropin releasing hormone
|
|
CRIM1
|
cysteine rich transmembrane BMP regulator 1 (chordin-like)
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRYAB
|
crystallin, alpha B
|
|
CSE1L
|
CSE1 chromosome segregation 1-like (yeast)
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSNK1G2
|
casein kinase 1, gamma 2
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CST2
|
cystatin SA
|
|
CST3
|
cystatin C
|
|
CST6
|
cystatin E/M
|
|
CST7
|
cystatin F (leukocystatin)
|
|
CSTA
|
cystatin A (stefin A)
|
|
CSTB
|
cystatin B (stefin B)
|
|
CTGF
|
connective tissue growth factor
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNNBIP1
|
catenin, beta interacting protein 1
|
|
CTSB
|
cathepsin B
|
|
CTSC
|
cathepsin C
|
|
CTSD
|
cathepsin D
|
|
CTSG
|
cathepsin G
|
|
CTSH
|
cathepsin H
|
|
CTSL
|
cathepsin L
|
|
CTSS
|
cathepsin S
|
|
CTSV
|
cathepsin V
|
|
CUL4A
|
cullin 4A
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CXADR
|
coxsackie virus and adenovirus receptor
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CXCR6
|
chemokine (C-X-C motif) receptor 6
|
|
CYC1
|
cytochrome c-1
|
|
CYCS
|
cytochrome c, somatic
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1
|
|
CYP2A6
|
cytochrome P450, family 2, subfamily A, polypeptide 6
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP3A
|
cytochrome P450, family 3, subfamily A
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
CYP51A1
|
cytochrome P450, family 51, subfamily A, polypeptide 1
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
CYTH2
|
cytohesin 2
|
|
DAB2IP
|
DAB2 interacting protein
|
|
DACH1
|
dachshund family transcription factor 1
|
|
DAXX
|
death-domain associated protein
|
|
DBI
|
diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein)
|
|
DCC
|
DCC netrin 1 receptor
|
|
DCLK1
|
doublecortin-like kinase 1
|
|
DCXR
|
dicarbonyl/L-xylulose reductase
|
|
DDB1
|
damage-specific DNA binding protein 1, 127kDa
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DDIT4
|
DNA-damage-inducible transcript 4
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DEFB103B
|
defensin, beta 103B
|
|
DEPTOR
|
DEP domain containing MTOR-interacting protein
|
|
DERL1
|
derlin 1
|
|
DES
|
desmin
|
|
DGAT1
|
diacylglycerol O-acyltransferase 1
|
|
DHFR
|
dihydrofolate reductase
|
|
DHX58
|
DEXH (Asp-Glu-X-His) box polypeptide 58
|
|
DIABLO
|
diablo, IAP-binding mitochondrial protein
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DLK1
|
delta-like 1 homolog (Drosophila)
|
|
DLL1
|
delta-like 1 (Drosophila)
|
|
DMP1
|
dentin matrix acidic phosphoprotein 1
|
|
DMPK
|
dystrophia myotonica-protein kinase
|
|
DNAJC3
|
DnaJ (Hsp40) homolog, subfamily C, member 3
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DOCK1
|
dedicator of cytokinesis 1
|
|
DOK1
|
docking protein 1, 62kDa (downstream of tyrosine kinase 1)
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DPP8
|
dipeptidyl-peptidase 8
|
|
DPP9
|
dipeptidyl-peptidase 9
|
|
DTL
|
denticleless E3 ubiquitin protein ligase homolog (Drosophila)
|
|
DYNC1I1
|
dynein, cytoplasmic 1, intermediate chain 1
|
|
DYRK1A
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A
|
|
DYRK1B
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B
|
|
E2F1
|
E2F transcription factor 1
|
|
ECE1
|
endothelin converting enzyme 1
|
|
ECSCR
|
endothelial cell surface expressed chemotaxis and apoptosis regulator
|
|
EGFL7
|
EGF-like-domain, multiple 7
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN1
|
egl-9 family hypoxia-inducible factor 1
|
|
EGLN2
|
egl-9 family hypoxia-inducible factor 2
|
|
EGR1
|
early growth response 1
|
|
EID3
|
EP300 interacting inhibitor of differentiation 3
|
|
EIF2A
|
eukaryotic translation initiation factor 2A, 65kDa
|
|
EIF2AK3
|
eukaryotic translation initiation factor 2-alpha kinase 3
|
|
EIF2AK4
|
eukaryotic translation initiation factor 2 alpha kinase 4
|
|
EIF2S1
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1
|
|
EIF4G2
|
eukaryotic translation initiation factor 4 gamma, 2
|
|
ELANE
|
elastase, neutrophil expressed
|
|
ELN
|
elastin
|
|
EML4
|
echinoderm microtubule associated protein like 4
|
|
ENAH
|
enabled homolog (Drosophila)
|
|
ENDOG
|
endonuclease G
|
|
ENPP2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2
|
|
ENTPD2
|
ectonucleoside triphosphate diphosphohydrolase 2
|
|
EPO
|
erythropoietin
|
|
EPOR
|
erythropoietin receptor
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERRFI1
|
ERBB receptor feedback inhibitor 1
|
|
ESPL1
|
extra spindle pole bodies homolog 1 (S. cerevisiae)
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
F10
|
coagulation factor X
|
|
F11
|
coagulation factor XI
|
|
F12
|
coagulation factor XII (Hageman factor)
|
|
F13A1
|
coagulation factor XIII, A1 polypeptide
|
|
F2
|
coagulation factor II (thrombin)
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
F8A1
|
coagulation factor VIII-associated 1
|
|
F9
|
coagulation factor IX
|
|
FAAH
|
fatty acid amide hydrolase
|
|
FAAH2
|
fatty acid amide hydrolase 2
|
|
FABP3
|
fatty acid binding protein 3, muscle and heart
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FANCA
|
Fanconi anemia, complementation group A
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FBXO5
|
F-box protein 5
|
|
FCGR1A
|
Fc fragment of IgG, high affinity Ia, receptor (CD64)
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCN2
|
ficolin (collagen/fibrinogen domain containing lectin) 2
|
|
FES
|
FES proto-oncogene, tyrosine kinase
|
|
FGA
|
fibrinogen alpha chain
|
|
FGB
|
fibrinogen beta chain
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF23
|
fibroblast growth factor 23
|
|
FGF7
|
fibroblast growth factor 7
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGR
|
FGR proto-oncogene, Src family tyrosine kinase
|
|
FHL2
|
four and a half LIM domains 2
|
|
FIP1L1
|
factor interacting with PAPOLA and CPSF1
|
|
FKBP1A
|
FK506 binding protein 1A, 12kDa
|
|
FKBP8
|
FK506 binding protein 8, 38kDa
|
|
FLG
|
filaggrin
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FN1
|
fibronectin 1
|
|
FNTA
|
farnesyltransferase, CAAX box, alpha
|
|
FNTB
|
farnesyltransferase, CAAX box, beta
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXP3
|
forkhead box P3
|
|
FPR2
|
formyl peptide receptor 2
|
|
FRMD7
|
FERM domain containing 7
|
|
FRS3
|
fibroblast growth factor receptor substrate 3
|
|
FST
|
follistatin
|
|
FURIN
|
furin (paired basic amino acid cleaving enzyme)
|
|
FUS
|
FUS RNA binding protein
|
|
GABPB1
|
GA binding protein transcription factor, beta subunit 1
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
GADD45G
|
growth arrest and DNA-damage-inducible, gamma
|
|
GADD45GIP1
|
growth arrest and DNA-damage-inducible, gamma interacting protein 1
|
|
GAS1
|
growth arrest-specific 1
|
|
GBF1
|
golgi brefeldin A resistant guanine nucleotide exchange factor 1
|
|
GCG
|
glucagon
|
|
GDF3
|
growth differentiation factor 3
|
|
GDF9
|
growth differentiation factor 9
|
|
GDI2
|
GDP dissociation inhibitor 2
|
|
GDNF
|
glial cell derived neurotrophic factor
|
|
GGH
|
gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase)
|
|
GIP
|
gastric inhibitory polypeptide
|
|
GLI1
|
GLI family zinc finger 1
|
|
GLS
|
glutaminase
|
|
GLS2
|
glutaminase 2 (liver, mitochondrial)
|
|
GMEB1
|
glucocorticoid modulatory element binding protein 1
|
|
GMNN
|
geminin, DNA replication inhibitor
|
|
GNAI1
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1
|
|
GNAS
|
GNAS complex locus
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GPR50
|
G protein-coupled receptor 50
|
|
GPSM1
|
G-protein signaling modulator 1
|
|
GPSM3
|
G-protein signaling modulator 3
|
|
GRAP2
|
GRB2-related adaptor protein 2
|
|
GRM3
|
glutamate receptor, metabotropic 3
|
|
GRN
|
granulin
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSN
|
gelsolin
|
|
GSPT1
|
G1 to S phase transition 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GTF3C1
|
general transcription factor IIIC, polypeptide 1, alpha 220kDa
|
|
GYPA
|
glycophorin A (MNS blood group)
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
GZMM
|
granzyme M (lymphocyte met-ase 1)
|
|
HABP2
|
hyaluronan binding protein 2
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HAO1
|
hydroxyacid oxidase (glycolate oxidase) 1
|
|
HAS2
|
hyaluronan synthase 2
|
|
HAVCR1
|
hepatitis A virus cellular receptor 1
|
|
HBG1
|
hemoglobin, gamma A
|
|
HBP1
|
HMG-box transcription factor 1
|
|
HCK
|
HCK proto-oncogene, Src family tyrosine kinase
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC3
|
histone deacetylase 3
|
|
HDAC6
|
histone deacetylase 6
|
|
HDAC8
|
histone deacetylase 8
|
|
HDAC9
|
histone deacetylase 9
|
|
HESX1
|
HESX homeobox 1
|
|
HEXIM1
|
hexamethylene bis-acetamide inducible 1
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HGFAC
|
HGF activator
|
|
HGS
|
hepatocyte growth factor-regulated tyrosine kinase substrate
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HINT1
|
histidine triad nucleotide binding protein 1
|
|
HIST3H3
|
histone cluster 3, H3
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HM13
|
histocompatibility (minor) 13
|
|
HMGB1
|
high mobility group box 1
|
|
HMGCL
|
3-hydroxymethyl-3-methylglutaryl-CoA lyase
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF1B
|
HNF1 homeobox B
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HNRNPA1
|
heterogeneous nuclear ribonucleoprotein A1
|
|
HNRNPD
|
heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa)
|
|
HOTS
|
H19 Opposite Tumor Suppressor
|
|
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD)
|
|
HPGDS
|
hematopoietic prostaglandin D synthase
|
|
HPN
|
hepsin
|
|
HPSE
|
heparanase
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HSD17B1
|
hydroxysteroid (17-beta) dehydrogenase 1
|
|
HSD3B1
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
|
|
HSD3B2
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSP90AB1
|
heat shock protein 90kDa alpha (cytosolic), class B member 1
|
|
HSP90B1
|
heat shock protein 90kDa beta (Grp94), member 1
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPA1B
|
heat shock 70kDa protein 1B
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPA9
|
heat shock 70kDa protein 9 (mortalin)
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
HTRA1
|
HtrA serine peptidase 1
|
|
HTRA2
|
HtrA serine peptidase 2
|
|
HTRA3
|
HtrA serine peptidase 3
|
|
IAPP
|
islet amyloid polypeptide
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICOSLG
|
inducible T-cell co-stimulator ligand
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
|
ID3
|
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein
|
|
ID4
|
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
|
IFIT2
|
interferon-induced protein with tetratricopeptide repeats 2
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IFT54
|
intraflagellar transport 54
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP5
|
insulin-like growth factor binding protein 5
|
|
IGFBP6
|
insulin-like growth factor binding protein 6
|
|
IGFBP7
|
insulin-like growth factor binding protein 7
|
|
IHG1
|
iris hypoplasia with glaucoma 1
|
|
IHH
|
indian hedgehog
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IKBKE
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IL10
|
interleukin 10
|
|
IL11
|
interleukin 11
|
|
IL13
|
interleukin 13
|
|
IL13RA1
|
interleukin 13 receptor, alpha 1
|
|
IL15
|
interleukin 15
|
|
IL15RA
|
interleukin 15 receptor, alpha
|
|
IL16
|
interleukin 16
|
|
IL17A
|
interleukin 17A
|
|
IL17D
|
interleukin 17D
|
|
IL18
|
interleukin 18
|
|
IL18BP
|
interleukin 18 binding protein
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL22
|
interleukin 22
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL27
|
interleukin 27
|
|
IL27RA
|
interleukin 27 receptor, alpha
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL2RG
|
interleukin 2 receptor, gamma
|
|
IL37
|
interleukin 37
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
IMPDH2
|
IMP (inosine 5'-monophosphate) dehydrogenase 2
|
|
INCA1
|
inhibitor of CDK, cyclin A1 interacting protein 1
|
|
ING1
|
inhibitor of growth family, member 1
|
|
ING4
|
inhibitor of growth family, member 4
|
|
ING5
|
inhibitor of growth family, member 5
|
|
INHBA
|
inhibin, beta A
|
|
INPP4B
|
inositol polyphosphate-4-phosphatase, type II, 105kDa
|
|
INS
|
insulin
|
|
INSL3
|
insulin-like 3 (Leydig cell)
|
|
INSR
|
insulin receptor
|
|
IP6K1
|
inositol hexakisphosphate kinase 1
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRF2
|
interferon regulatory factor 2
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRS1
|
insulin receptor substrate 1
|
|
ITCH
|
itchy E3 ubiquitin protein ligase
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGA7
|
integrin, alpha 7
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB5
|
integrin, beta 5
|
|
ITIH1
|
inter-alpha-trypsin inhibitor heavy chain 1
|
|
ITIH4
|
inter-alpha-trypsin inhibitor heavy chain family, member 4
|
|
ITM2B
|
integral membrane protein 2B
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
JUN
|
jun proto-oncogene
|
|
JUNB
|
jun B proto-oncogene
|
|
JUND
|
jun D proto-oncogene
|
|
JUP
|
junction plakoglobin
|
|
KCNA1
|
potassium channel, voltage gated shaker related subfamily A, member 1
|
|
KCNA4
|
potassium channel, voltage gated shaker related subfamily A, member 4
|
|
KCNQ1OT1
|
KCNQ1 opposite strand/antisense transcript 1 (non-protein coding)
|
|
KCTD1
|
potassium channel tetramerization domain containing 1
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KDM2A
|
lysine (K)-specific demethylase 2A
|
|
KDM8
|
lysine (K)-specific demethylase 8
|
|
KDR
|
kinase insert domain receptor
|
|
KEAP1
|
kelch-like ECH-associated protein 1
|
|
KHDRBS1
|
KH domain containing, RNA binding, signal transduction associated 1
|
|
KIAA1524
|
KIAA1524
|
|
KIF11
|
kinesin family member 11
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KL
|
klotho
|
|
KLF2
|
Kruppel-like factor 2
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLF5
|
Kruppel-like factor 5 (intestinal)
|
|
KLF6
|
Kruppel-like factor 6
|
|
KLK1
|
kallikrein 1
|
|
KLK12
|
kallikrein-related peptidase 12
|
|
KLK13
|
kallikrein-related peptidase 13
|
|
KLK14
|
kallikrein-related peptidase 14
|
|
KLK5
|
kallikrein-related peptidase 5
|
|
KLK6
|
kallikrein-related peptidase 6
|
|
KLK7
|
kallikrein-related peptidase 7
|
|
KLKB1
|
kallikrein B, plasma (Fletcher factor) 1
|
|
KLLN
|
killin, p53-regulated DNA replication inhibitor
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KPNA1
|
karyopherin alpha 1 (importin alpha 5)
|
|
KPNA2
|
karyopherin alpha 2 (RAG cohort 1, importin alpha 1)
|
|
KPNB1
|
karyopherin (importin) beta 1
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT19
|
keratin 19, type I
|
|
LACRT
|
lacritin
|
|
LAMC2
|
laminin, gamma 2
|
|
LAT
|
linker for activation of T cells
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LCN2
|
lipocalin 2
|
|
LCOR
|
ligand dependent nuclear receptor corepressor
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LEP
|
leptin
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS2
|
lectin, galactoside-binding, soluble, 2
|
|
LGALS7
|
lectin, galactoside-binding, soluble, 7
|
|
LGALS9
|
lectin, galactoside-binding, soluble, 9
|
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
|
|
LILRB4
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4
|
|
LMNA
|
lamin A/C
|
|
LOXL1
|
lysyl oxidase-like 1
|
|
LPA
|
lipoprotein, Lp(a)
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
LRP6
|
low density lipoprotein receptor-related protein 6
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LSS
|
lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase)
|
|
LTF
|
lactotransferrin
|
|
LY9
|
lymphocyte antigen 9
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
LYPLA1
|
lysophospholipase I
|
|
LYZ
|
lysozyme
|
|
MAD1L1
|
MAD1 mitotic arrest deficient-like 1 (yeast)
|
|
MAD2L1
|
MAD2 mitotic arrest deficient-like 1 (yeast)
|
|
MAF1
|
MAF1 homolog (S. cerevisiae)
|
|
MAFG
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog G
|
|
MAGED1
|
melanoma antigen family D1
|
|
MALT1
|
MALT1 paracaspase
|
|
MAOA
|
monoamine oxidase A
|
|
MAOB
|
monoamine oxidase B
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAP2K7
|
mitogen-activated protein kinase kinase 7
|
|
MAP3K11
|
mitogen-activated protein kinase kinase kinase 11
|
|
MAP3K4
|
mitogen-activated protein kinase kinase kinase 4
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAP3K7
|
mitogen-activated protein kinase kinase kinase 7
|
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK12
|
mitogen-activated protein kinase 12
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2
|
|
MAPT
|
microtubule-associated protein tau
|
|
MASP1
|
mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor)
|
|
MATN1
|
matrilin 1, cartilage matrix protein
|
|
MBNL3
|
muscleblind-like splicing regulator 3
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MELK
|
maternal embryonic leucine zipper kinase
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MEOX2
|
mesenchyme homeobox 2
|
|
MEP1A
|
meprin A, alpha (PABA peptide hydrolase)
|
|
MEP1B
|
meprin A, beta
|
|
MESDC2
|
mesoderm development candidate 2
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGAM
|
maltase-glucoamylase
|
|
MGAT5
|
mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MGP
|
matrix Gla protein
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR101-1
|
microRNA 101-1
|
|
MIR122
|
microRNA 122
|
|
MIR125B1
|
microRNA 125b-1
|
|
MIR126
|
microRNA 126
|
|
MIR1275
|
microRNA 1275
|
|
MIR1301
|
microRNA 1301
|
|
MIR130A
|
microRNA 130a
|
|
MIR132
|
microRNA 132
|
|
MIR146A
|
microRNA 146a
|
|
MIR150
|
microRNA 150
|
|
MIR17
|
microRNA 17
|
|
MIR181A2
|
microRNA 181a-2
|
|
MIR196A1
|
microRNA 196a-1
|
|
MIR199B
|
microRNA 199b
|
|
MIR19A
|
microRNA 19a
|
|
MIR200A
|
microRNA 200a
|
|
MIR200C
|
microRNA 200c
|
|
MIR20B
|
microRNA 20b
|
|
MIR21
|
microRNA 21
|
|
MIR217
|
microRNA 217
|
|
MIR221
|
microRNA 221
|
|
MIR25
|
microRNA 25
|
|
MIR27A
|
microRNA 27a
|
|
MIR27B
|
microRNA 27b
|
|
MIR29B1
|
microRNA 29b-1
|
|
MIR452
|
microRNA 452
|
|
MIR9-1
|
microRNA 9-1
|
|
MIR96
|
microRNA 96
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMEL1
|
membrane metallo-endopeptidase-like 1
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP10
|
matrix metallopeptidase 10
|
|
MMP12
|
matrix metallopeptidase 12
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP16
|
matrix metallopeptidase 16 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP28
|
matrix metallopeptidase 28
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP8
|
matrix metallopeptidase 8
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPO
|
myeloperoxidase
|
|
MPRIP
|
myosin phosphatase Rho interacting protein
|
|
MRAP2
|
melanocortin 2 receptor accessory protein 2
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MSH2
|
mutS homolog 2
|
|
MSI1
|
musashi RNA-binding protein 1
|
|
MTAP
|
methylthioadenosine phosphorylase
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC4
|
mucin 4, cell surface associated
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MYBL2
|
v-myb avian myeloblastosis viral oncogene homolog-like 2
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
MYO18B
|
myosin XVIIIB
|
|
NAA10
|
N(alpha)-acetyltransferase 10, NatA catalytic subunit
|
|
NAA50
|
N(alpha)-acetyltransferase 50, NatE catalytic subunit
|
|
NAE1
|
NEDD8 activating enzyme E1 subunit 1
|
|
NAIP
|
NLR family, apoptosis inhibitory protein
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NANOG
|
Nanog homeobox
|
|
NAPRT
|
nicotinate phosphoribosyltransferase
|
|
NAT1
|
N-acetyltransferase 1 (arylamine N-acetyltransferase)
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NDRG2
|
NDRG family member 2
|
|
NDUFA13
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13
|
|
NEDD8
|
neural precursor cell expressed, developmentally down-regulated 8
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFATC4
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NFKBIZ
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta
|
|
NGB
|
neuroglobin
|
|
NLRP10
|
NLR family, pyrin domain containing 10
|
|
NOL3
|
nucleolar protein 3 (apoptosis repressor with CARD domain)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOX1
|
NADPH oxidase 1
|
|
NOXA1
|
NADPH oxidase activator 1
|
|
NPC1L1
|
NPC1-like 1
|
|
NPEPPS
|
aminopeptidase puromycin sensitive
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NQO2
|
NAD(P)H dehydrogenase, quinone 2
|
|
NR0B2
|
nuclear receptor subfamily 0, group B, member 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRF1
|
nuclear respiratory factor 1
|
|
NRG1
|
neuregulin 1
|
|
NTN1
|
netrin 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NUCB1
|
nucleobindin 1
|
|
OAZ1
|
ornithine decarboxylase antizyme 1
|
|
OLIG2
|
oligodendrocyte lineage transcription factor 2
|
|
OSGIN1
|
oxidative stress induced growth inhibitor 1
|
|
OSM
|
oncostatin M
|
|
OTUB1
|
OTU deubiquitinase, ubiquitin aldehyde binding 1
|
|
OTX2
|
orthodenticle homeobox 2
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P2RY12
|
purinergic receptor P2Y, G-protein coupled, 12
|
|
P2RY6
|
pyrimidinergic receptor P2Y, G-protein coupled, 6
|
|
PA2G4
|
proliferation-associated 2G4, 38kDa
|
|
PADI4
|
peptidyl arginine deiminase, type IV
|
|
PAH
|
phenylalanine hydroxylase
|
|
PAK2
|
p21 protein (Cdc42/Rac)-activated kinase 2
|
|
PAK4
|
p21 protein (Cdc42/Rac)-activated kinase 4
|
|
PANX1
|
pannexin 1
|
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PARP2
|
poly (ADP-ribose) polymerase 2
|
|
PAX3
|
paired box 3
|
|
PAXIP1
|
PAX interacting (with transcription-activation domain) protein 1
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PCSK6
|
proprotein convertase subtilisin/kexin type 6
|
|
PCSK9
|
proprotein convertase subtilisin/kexin type 9
|
|
PCYT1B
|
phosphate cytidylyltransferase 1, choline, beta
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PDCD6IP
|
programmed cell death 6 interacting protein
|
|
PDCL
|
phosducin-like
|
|
PDE2A
|
phosphodiesterase 2A, cGMP-stimulated
|
|
PDE3A
|
phosphodiesterase 3A, cGMP-inhibited
|
|
PDE3B
|
phosphodiesterase 3B, cGMP-inhibited
|
|
PDE4A
|
phosphodiesterase 4A, cAMP-specific
|
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific
|
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific
|
|
PDE5A
|
phosphodiesterase 5A, cGMP-specific
|
|
PDE7A
|
phosphodiesterase 7A
|
|
PDE9A
|
phosphodiesterase 9A
|
|
PDGFA
|
platelet-derived growth factor alpha polypeptide
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDIA3
|
protein disulfide isomerase family A, member 3
|
|
PDK4
|
pyruvate dehydrogenase kinase, isozyme 4
|
|
PDLIM5
|
PDZ and LIM domain 5
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase 1
|
|
PDPN
|
podoplanin
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PEPD
|
peptidase D
|
|
PF4
|
platelet factor 4
|
|
PFKFB3
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
|
|
PFN1
|
profilin 1
|
|
PGR
|
progesterone receptor
|
|
PGRMC2
|
progesterone receptor membrane component 2
|
|
PHB
|
prohibitin
|
|
PI3
|
peptidase inhibitor 3, skin-derived
|
|
PIAS1
|
protein inhibitor of activated STAT, 1
|
|
PIAS3
|
protein inhibitor of activated STAT, 3
|
|
PIAS4
|
protein inhibitor of activated STAT, 4
|
|
PICK1
|
protein interacting with PRKCA 1
|
|
PID1
|
phosphotyrosine interaction domain containing 1
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PIM2
|
Pim-2 proto-oncogene, serine/threonine kinase
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PINX1
|
PIN2/TERF1 interacting, telomerase inhibitor 1
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
|
PKM
|
pyruvate kinase, muscle
|
|
PLA2G10
|
phospholipase A2, group X
|
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLAT
|
plasminogen activator, tissue
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLG
|
plasminogen
|
|
PLIN3
|
perilipin 3
|
|
PLK1
|
polo-like kinase 1
|
|
PLN
|
phospholamban
|
|
PML
|
promyelocytic leukemia
|
|
PNLIP
|
pancreatic lipase
|
|
PNMT
|
phenylethanolamine N-methyltransferase
|
|
PNP
|
purine nucleoside phosphorylase
|
|
PNPLA4
|
patatin-like phospholipase domain containing 4
|
|
PNPLA6
|
patatin-like phospholipase domain containing 6
|
|
POLH
|
polymerase (DNA directed), eta
|
|
POU2F1
|
POU class 2 homeobox 1
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPIA
|
peptidylprolyl isomerase A (cyclophilin A)
|
|
PPID
|
peptidylprolyl isomerase D
|
|
PPM1D
|
protein phosphatase, Mg2+/Mn2+ dependent, 1D
|
|
PPP1R13L
|
protein phosphatase 1, regulatory subunit 13 like
|
|
PPP1R14C
|
protein phosphatase 1, regulatory (inhibitor) subunit 14C
|
|
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B
|
|
PPP1R2
|
protein phosphatase 1, regulatory (inhibitor) subunit 2
|
|
PPP1R2P3
|
protein phosphatase 1, regulatory (inhibitor) subunit 2 pseudogene 3
|
|
PPP2R1B
|
protein phosphatase 2, regulatory subunit A, beta
|
|
PPP2R2C
|
protein phosphatase 2, regulatory subunit B, gamma
|
|
PRDX1
|
peroxiredoxin 1
|
|
PRDX3
|
peroxiredoxin 3
|
|
PRDX5
|
peroxiredoxin 5
|
|
PREP
|
prolyl endopeptidase
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PRL
|
prolactin
|
|
PRLR
|
prolactin receptor
|
|
PRMT3
|
protein arginine methyltransferase 3
|
|
PRNP
|
prion protein
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROL1
|
proline rich, lacrimal 1
|
|
PROS1
|
protein S (alpha)
|
|
PROX1
|
prospero homeobox 1
|
|
PROZ
|
protein Z, vitamin K-dependent plasma glycoprotein
|
|
PRPS1
|
phosphoribosyl pyrophosphate synthetase 1
|
|
PRSS1
|
protease, serine, 1 (trypsin 1)
|
|
PRSS3
|
protease, serine, 3
|
|
PRTN3
|
proteinase 3
|
|
PSAP
|
prosaposin
|
|
PSEN1
|
presenilin 1
|
|
PSMA3
|
proteasome (prosome, macropain) subunit, alpha type, 3
|
|
PSMC5
|
proteasome (prosome, macropain) 26S subunit, ATPase, 5
|
|
PSPH
|
phosphoserine phosphatase
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain)
|
|
PTGES
|
prostaglandin E synthase
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTK6
|
protein tyrosine kinase 6
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
PTX3
|
pentraxin 3, long
|
|
PUS1
|
pseudouridylate synthase 1
|
|
PXN
|
paxillin
|
|
QPCT
|
glutaminyl-peptide cyclotransferase
|
|
QPRT
|
quinolinate phosphoribosyltransferase
|
|
RAB11A
|
RAB11A, member RAS oncogene family
|
|
RAB14
|
RAB14, member RAS oncogene family
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD23B
|
RAD23 homolog B (S. cerevisiae)
|
|
RAD51
|
RAD51 recombinase
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RAG2
|
recombination activating gene 2
|
|
RAP1GAP
|
RAP1 GTPase activating protein
|
|
RAP2A
|
RAP2A, member of RAS oncogene family
|
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3
|
|
RASGRF1
|
Ras protein-specific guanine nucleotide-releasing factor 1
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RASSF5
|
Ras association (RalGDS/AF-6) domain family member 5
|
|
RB1
|
retinoblastoma 1
|
|
RCAN1
|
regulator of calcineurin 1
|
|
RECK
|
reversion-inducing-cysteine-rich protein with kazal motifs
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RELB
|
v-rel avian reticuloendotheliosis viral oncogene homolog B
|
|
REN
|
renin
|
|
RET
|
ret proto-oncogene
|
|
RGMA
|
repulsive guidance molecule family member a
|
|
RGS2
|
regulator of G-protein signaling 2
|
|
RHEB
|
Ras homolog enriched in brain
|
|
RHOA
|
ras homolog family member A
|
|
RHOB
|
ras homolog family member B
|
|
RHOH
|
ras homolog family member H
|
|
RIPK1
|
receptor (TNFRSF)-interacting serine-threonine kinase 1
|
|
RIPK3
|
receptor-interacting serine-threonine kinase 3
|
|
RNASE2
|
ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin)
|
|
RNASE7
|
ribonuclease, RNase A family, 7
|
|
RNASEK
|
ribonuclease, RNase K
|
|
RNASEL
|
ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent)
|
|
RND3
|
Rho family GTPase 3
|
|
RNF115
|
ring finger protein 115
|
|
RNF41
|
ring finger protein 41, E3 ubiquitin protein ligase
|
|
RNH1
|
ribonuclease/angiogenin inhibitor 1
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
ROS1
|
ROS proto-oncogene 1 , receptor tyrosine kinase
|
|
RPL11
|
ribosomal protein L11
|
|
RPS19BP1
|
ribosomal protein S19 binding protein 1
|
|
RPS27
|
ribosomal protein S27
|
|
RPS6
|
ribosomal protein S6
|
|
RPS6KA3
|
ribosomal protein S6 kinase, 90kDa, polypeptide 3
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RPSA
|
ribosomal protein SA
|
|
RRM1
|
ribonucleotide reductase M1
|
|
RRM2
|
ribonucleotide reductase M2
|
|
RTN4
|
reticulon 4
|
|
RTN4R
|
reticulon 4 receptor
|
|
RTN4RL2
|
reticulon 4 receptor-like 2
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RXFP2
|
relaxin/insulin-like family peptide receptor 2
|
|
S100A11
|
S100 calcium binding protein A11
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
|
S1PR2
|
sphingosine-1-phosphate receptor 2
|
|
SAA1
|
serum amyloid A1
|
|
SALL4
|
spalt-like transcription factor 4
|
|
SCNN1G
|
sodium channel, non voltage gated 1 gamma subunit
|
|
SDC1
|
syndecan 1
|
|
SDC4
|
syndecan 4
|
|
SDCBP
|
syndecan binding protein (syntenin)
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F
|
|
SEMA6A
|
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A
|
|
SEMG1
|
semenogelin I
|
|
SEMG2
|
semenogelin II
|
|
SENP8
|
SUMO/sentrin specific peptidase family member 8
|
|
SEPT4
|
septin 4
|
|
SEPW1
|
selenoprotein W, 1
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINA10
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10
|
|
SERPINA3
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3
|
|
SERPINA4
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4
|
|
SERPINA5
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5
|
|
SERPINB1
|
serpin peptidase inhibitor, clade B (ovalbumin), member 1
|
|
SERPINB13
|
serpin peptidase inhibitor, clade B (ovalbumin), member 13
|
|
SERPINB2
|
serpin peptidase inhibitor, clade B (ovalbumin), member 2
|
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
|
SERPINB9
|
serpin peptidase inhibitor, clade B (ovalbumin), member 9
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINE2
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2
|
|
SERPINF2
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2
|
|
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
|
|
SERPINI1
|
serpin peptidase inhibitor, clade I (neuroserpin), member 1
|
|
SET
|
SET nuclear proto-oncogene
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SFRP4
|
secreted frizzled-related protein 4
|
|
SFTPD
|
surfactant protein D
|
|
SH2B3
|
SH2B adaptor protein 3
|
|
SHH
|
sonic hedgehog
|
|
SHOC2
|
soc-2 suppressor of clear homolog (C. elegans)
|
|
SIGIRR
|
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain
|
|
SIGMAR1
|
sigma non-opioid intracellular receptor 1
|
|
SIRT1
|
sirtuin 1
|
|
SIRT2
|
sirtuin 2
|
|
SIRT3
|
sirtuin 3
|
|
SKIL
|
SKI-like proto-oncogene
|
|
SKP1
|
S-phase kinase-associated protein 1
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLC14A1
|
solute carrier family 14 (urea transporter), member 1 (Kidd blood group)
|
|
SLC15A1
|
solute carrier family 15 (oligopeptide transporter), member 1
|
|
SLC15A2
|
solute carrier family 15 (oligopeptide transporter), member 2
|
|
SLC18A2
|
solute carrier family 18 (vesicular monoamine transporter), member 2
|
|
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1
|
|
SLC30A1
|
solute carrier family 30 (zinc transporter), member 1
|
|
SLC36A1
|
solute carrier family 36 (proton/amino acid symporter), member 1
|
|
SLC4A1
|
solute carrier family 4 (anion exchanger), member 1 (Diego blood group)
|
|
SLC5A2
|
solute carrier family 5 (sodium/glucose cotransporter), member 2
|
|
SLC6A11
|
solute carrier family 6 (neurotransmitter transporter), member 11
|
|
SLC6A13
|
solute carrier family 6 (neurotransmitter transporter), member 13
|
|
SLC6A2
|
solute carrier family 6 (neurotransmitter transporter), member 2
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC6A6
|
solute carrier family 6 (neurotransmitter transporter), member 6
|
|
SLC7A11
|
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11
|
|
SLCO1B1
|
solute carrier organic anion transporter family, member 1B1
|
|
SLIT2
|
slit homolog 2 (Drosophila)
|
|
SLPI
|
secretory leukocyte peptidase inhibitor
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD4
|
SMAD family member 4
|
|
SMAD7
|
SMAD family member 7
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SMN2
|
survival of motor neuron 2, centromeric
|
|
SMO
|
smoothened, frizzled class receptor
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNPH
|
syntaphilin
|
|
SOAT1
|
sterol O-acyltransferase 1
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOSTDC1
|
sclerostin domain containing 1
|
|
SOX17
|
SRY (sex determining region Y)-box 17
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX4
|
SRY (sex determining region Y)-box 4
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SP1
|
Sp1 transcription factor
|
|
SPAG11B
|
sperm associated antigen 11B
|
|
SPDEF
|
SAM pointed domain containing ETS transcription factor
|
|
SPHK1
|
sphingosine kinase 1
|
|
SPHK2
|
sphingosine kinase 2
|
|
SPHKAP
|
SPHK1 interactor, AKAP domain containing
|
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1
|
|
SPINK5
|
serine peptidase inhibitor, Kazal type 5
|
|
SPINK6
|
serine peptidase inhibitor, Kazal type 6
|
|
SPINK7
|
serine peptidase inhibitor, Kazal type 7 (putative)
|
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1
|
|
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2
|
|
SPINT3
|
serine peptidase inhibitor, Kunitz type, 3
|
|
SPRED3
|
sprouty-related, EVH1 domain containing 3
|
|
SPRY1
|
sprouty homolog 1, antagonist of FGF signaling (Drosophila)
|
|
SPRY2
|
sprouty homolog 2 (Drosophila)
|
|
SRA1
|
steroid receptor RNA activator 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRCIN1
|
SRC kinase signaling inhibitor 1
|
|
SRF
|
serum response factor (c-fos serum response element-binding transcription factor)
|
|
SRR
|
serine racemase
|
|
SRSF1
|
serine/arginine-rich splicing factor 1
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STC1
|
stanniocalcin 1
|
|
STC2
|
stanniocalcin 2
|
|
STIM2
|
stromal interaction molecule 2
|
|
STIP1
|
stress-induced phosphoprotein 1
|
|
STK11
|
serine/threonine kinase 11
|
|
STK3
|
serine/threonine kinase 3
|
|
STUB1
|
STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase
|
|
STX6
|
syntaxin 6
|
|
SUMO1
|
small ubiquitin-like modifier 1
|
|
SUV39H1
|
suppressor of variegation 3-9 homolog 1 (Drosophila)
|
|
SVIL
|
supervillin
|
|
SVIP
|
small VCP/p97-interacting protein
|
|
SYK
|
spleen tyrosine kinase
|
|
TAS1R2
|
taste receptor, type 1, member 2
|
|
TAS1R3
|
taste receptor, type 1, member 3
|
|
TBC1D10C
|
TBC1 domain family, member 10C
|
|
TBXAS1
|
thromboxane A synthase 1 (platelet)
|
|
TCF3
|
transcription factor 3
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TDG
|
thymine-DNA glycosylase
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TERF1
|
telomeric repeat binding factor (NIMA-interacting) 1
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET1
|
tet methylcytosine dioxygenase 1
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TF
|
transferrin
|
|
TFF1
|
trefoil factor 1
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TFPI2
|
tissue factor pathway inhibitor 2
|
|
TFRC
|
transferrin receptor
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
TGFB3
|
transforming growth factor, beta 3
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGFBR3
|
transforming growth factor, beta receptor III
|
|
TGM2
|
transglutaminase 2
|
|
THBD
|
thrombomodulin
|
|
THBS1
|
thrombospondin 1
|
|
THBS2
|
thrombospondin 2
|
|
THNSL2
|
threonine synthase-like 2 (S. cerevisiae)
|
|
TICAM1
|
toll-like receptor adaptor molecule 1
|
|
TICAM2
|
toll-like receptor adaptor molecule 2
|
|
TIGIT
|
T cell immunoreceptor with Ig and ITIM domains
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TIMP4
|
TIMP metallopeptidase inhibitor 4
|
|
TIPE2
|
TNF alpha induced protein 8 like 2
|
|
TK1
|
thymidine kinase 1, soluble
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR9
|
toll-like receptor 9
|
|
TMBIM6
|
transmembrane BAX inhibitor motif containing 6
|
|
TMPRSS6
|
transmembrane protease, serine 6
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF9
|
tumor necrosis factor receptor superfamily, member 9
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TNFSF15
|
tumor necrosis factor (ligand) superfamily, member 15
|
|
TNFSF9
|
tumor necrosis factor (ligand) superfamily, member 9
|
|
TNK2
|
tyrosine kinase, non-receptor, 2
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TOPORS
|
topoisomerase I binding, arginine/serine-rich, E3 ubiquitin protein ligase
|
|
TP53
|
tumor protein p53
|
|
TP53BP1
|
tumor protein p53 binding protein 1
|
|
TP53BP2
|
tumor protein p53 binding protein 2
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPP1
|
tripeptidyl peptidase I
|
|
TPSAB1
|
tryptase alpha/beta 1
|
|
TPT1
|
tumor protein, translationally-controlled 1
|
|
TRAF1
|
TNF receptor-associated factor 1
|
|
TRIM33
|
tripartite motif containing 33
|
|
TRIM39
|
tripartite motif containing 39
|
|
TRIM40
|
tripartite motif containing 40
|
|
TRIM5
|
tripartite motif containing 5
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
|
TRPC3
|
transient receptor potential cation channel, subfamily C, member 3
|
|
TRPM7
|
transient receptor potential cation channel, subfamily M, member 7
|
|
TRPV2
|
transient receptor potential cation channel, subfamily V, member 2
|
|
TRPV4
|
transient receptor potential cation channel, subfamily V, member 4
|
|
TRPV5
|
transient receptor potential cation channel, subfamily V, member 5
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSC22D3
|
TSC22 domain family, member 3
|
|
TTBK1
|
tau tubulin kinase 1
|
|
TTK
|
TTK protein kinase
|
|
TTR
|
transthyretin
|
|
TUBB6
|
tubulin, beta 6 class V
|
|
TUSC2
|
tumor suppressor candidate 2
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TXN
|
thioredoxin
|
|
TXNIP
|
thioredoxin interacting protein
|
|
TXNRD1
|
thioredoxin reductase 1
|
|
TYR
|
tyrosinase
|
|
UBC
|
ubiquitin C
|
|
UBE2I
|
ubiquitin-conjugating enzyme E2I
|
|
UBE3C
|
ubiquitin protein ligase E3C
|
|
UBQLN1
|
ubiquilin 1
|
|
UCHL3
|
ubiquitin carboxyl-terminal esterase L3 (ubiquitin thiolesterase)
|
|
UCHL5
|
ubiquitin carboxyl-terminal hydrolase L5
|
|
UGT1A8
|
UDP glucuronosyltransferase 1 family, polypeptide A8
|
|
UGT1A9
|
UDP glucuronosyltransferase 1 family, polypeptide A9
|
|
ULBP1
|
UL16 binding protein 1
|
|
UNC5CL
|
unc-5 homolog C (C. elegans)-like
|
|
USF1
|
upstream transcription factor 1
|
|
USP14
|
ubiquitin specific peptidase 14 (tRNA-guanine transglycosylase)
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VCAN
|
versican
|
|
VCP
|
valosin containing protein
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VGLL3
|
vestigial-like family member 3
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIM
|
vimentin
|
|
VPRBP
|
Vpr (HIV-1) binding protein
|
|
VSIG4
|
V-set and immunoglobulin domain containing 4
|
|
VTN
|
vitronectin
|
|
VWF
|
von Willebrand factor
|
|
WDR34
|
WD repeat domain 34
|
|
WEE1
|
WEE1 G2 checkpoint kinase
|
|
WFDC1
|
WAP four-disulfide core domain 1
|
|
WFDC2
|
WAP four-disulfide core domain 2
|
|
WNK4
|
WNK lysine deficient protein kinase 4
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
XBP1
|
X-box binding protein 1
|
|
XDH
|
xanthine dehydrogenase
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XPO1
|
exportin 1
|
|
YBX1
|
Y box binding protein 1
|
|
YWHAQ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta
|
|
YY1
|
YY1 transcription factor
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
|
ZC3H12C
|
zinc finger CCCH-type containing 12C
|
|
ZFP36
|
ZFP36 ring finger protein
|
|
ZMYM4
|
zinc finger, MYM-type 4
|
|
ZNF148
|
zinc finger protein 148
|
|
ZNF205
|
zinc finger protein 205
|
|
ZNHIT1
|
zinc finger, HIT-type containing 1
|
